Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIF - Post by User

IMV Inc
Bullboard Posts
User Avatar Image
(17)
•••
Post by alphaseeking001on May 05, 2019 9:41am
97 Views
Post# 29712062

If the overall market corrects?

If the overall market corrects?Given that we are entering “sell in May and go away” time and it coinciding with overall market highs any concern that potential good news in the next 6 weeks might get caught in any downdraft from the overall market?  Or can small biotechs with good clinical results (hopefully) fly against the trend in the market?  I’m happy we seem to have broken the brutal downtrend this week but am wondering about market timing.  I’m probably overthinking it.  Thoughts?
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities